Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response

2017 ◽  
Vol 46 (6) ◽  
pp. 605-616 ◽  
Author(s):  
A. K. Le ◽  
C. Zhao ◽  
J. K. Hoang ◽  
S. A. Tran ◽  
C. Y. Chang ◽  
...  
Keyword(s):  
Overall Survival ◽  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis C ◽  
Sustained Virological Response ◽  
Chronic Hepatitis C ◽  
Virological Response ◽  
Ethnic Disparities ◽  
Advanced Liver Disease

SVR reduces ethnic disparities in progression to advanced liver disease in patients with chronic hepatitis C

2017 ◽  
Vol 66 (1) ◽  
pp. S283-S284
Author(s):  
A.K. Le ◽  
C. Zhao ◽  
J. Hoang ◽  
L.A. Yasukawa ◽  
J. Zhang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Ethnic Disparities ◽  
Advanced Liver Disease

scholarly journals Chronic hepatitis С and non-alcoholic fatty liver disease. Main aspects of pathogenesis

2018 ◽  
Vol 20 (1) ◽  
pp. 216-221
Author(s):  
K V Zhdanov ◽  
S S Karyakin ◽  
K V Kozlov ◽  
D A Gusev ◽  
V S Sukachev ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis C ◽  
Fatty Liver ◽  
Sustained Virological Response ◽  
Chronic Hepatitis C ◽  
Virological Response ◽  
Fatty Liver Disease ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Fatty Liver Disease

The main pathogenetic aspects of non-alcoholic fatty liver disease as a comorbid factor of chronic hepatitis C are considered. Non-alcoholic fatty liver disease is currently the most common liver disease worldwide, both among adults and children. It is usually accompanied by obesity, insulin resistance and diabetes mellitus. Non-alcoholic fatty liver disease includes a spectrum of pathologies from simple fatty liver infiltration to non-alcoholic steatohepatitis, which is characterized by inflammation with potential progression to fibrosis and cirrhosis over time. On average, non-alcoholic fatty liver disease occurs in 55% of patients with chronic hepatitis C, which is significantly higher than the prevalence of each disease individually. This condition leads to a greater rate of progression of fibrosis, as well as a continuing high risk of developing cirrhosis and hepatocellular carcinoma even after achieving a sustained virological response. In this regard, complex therapy aimed at normalization of the nutritional status, optimization of body weight, correction of impaired intestinal microflora, reduction of severity of liver steatosis and achieving a sustained virological response is a priority task in the treatment of patients with chronic hepatitis C.

Early prediction of sustained virological response at day 3 of treatment with albinterferon-α-2b in patients with genotype 2/3 chronic hepatitis C

2009 ◽  
Vol 29 (9) ◽  
pp. 1350-1355 ◽  
Author(s):  
Avidan U. Neumann ◽  
Vincent G. Bain ◽  
Eric M. Yoshida ◽  
Keyur Patel ◽  
Erik Pulkstenis ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Sustained Virological Response ◽  
Chronic Hepatitis C ◽  
Virological Response ◽  
Early Prediction ◽  
Genotype 2
Sign in / Sign up

Export Citation Format

Share Document